Skip to main content
HR 1885 106th Congress House

International Prescription Drug Parity Act

Official title: To amend the Federal Food, Drug, and Cosmetic Act to provide for facilitating the importation into the United States of certain drugs that have been approved by the Food and Drug Administration.

Introduced: October 20, 1999 See on congress.gov
Health Administrative procedureBusiness recordsCommerceDepartment of Health and Human Services
More subjectsShow fewer subjects
Drug approvalsDrug industryExportsForeign Trade and International FinanceGovernment Operations and PoliticsGovernment paperworkImportsLabelingLaw
Sign in to write a letter Sign in to watch
This bill died when the 106th Congress ended
It never became law before the 106th Congress (1999–2000) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 12, 2000
Sponsor introductory remarks on measure. (CR H2186-2187)
Jun 15, 1999
Referred to the Subcommittee on Health and Environment.
May 20, 1999
Referred to the House Committee on Commerce.
May 20, 1999
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 12, 2000

Sponsor introductory remarks on measure. (CR H2186-2187)

 Plain-English summary Congressional Research Service

International Prescription Drug Parity Act - Amends the Federal Food, Drug, and Cosmetic Act to require manufacturers of certain drugs manufactured and domestically approved and then exported, or domestically approved and manufactured in a registered foreign establishment, to: (1) maintain specified shipment compliance and labeling records; and (2) make such records available to U.S. importers.

Directs the Secretary of Health and Human Services to establish related criteria to facilitate the U.S. importation of such drugs.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 15
All 15 Democratic 9 Republican 1 Independent 1
D
McGovern, James P.
Massachusetts · Jul 10, 2000
STENHOLM, CHARLES
· Jun 20, 2000
 D
DeLauro, Rosa L.
Connecticut · Apr 12, 2000
 R
Wicker, Roger F.
Mississippi · Apr 12, 2000
 D
Davis, Danny K.
Illinois · Apr 10, 2000
 D
Doggett, Lloyd
Texas · Apr 10, 2000
LIPINSKI, WILLIAM
· Apr 10, 2000
 D
Kaptur, Marcy
Ohio · Feb 9, 2000
 D
Larson, John B.
Connecticut · Nov 2, 1999
 D
Nadler, Jerrold
New York · Nov 2, 1999
 D
Baldwin, Tammy
Wisconsin · Nov 1, 1999
 D
Schakowsky, Janice D.
Illinois · Oct 20, 1999
SANDLIN, MAX
· Jul 29, 1999
BEREUTER, DOUGLAS
· Jul 19, 1999
 I
Sanders, Bernard
Vermont · May 20, 1999
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1885: International Prescription Drug Parity Act. 106th Congress. Open America. https://openamerica.io/bill/106-HR-1885/
MLA
"H.R. 1885: International Prescription Drug Parity Act." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HR-1885/.
Bluebook (legal)
H.R. 1885, 106th Cong. (2026), https://openamerica.io/bill/106-HR-1885/.
Markdown link
[H.R. 1885: International Prescription Drug Parity Act](https://openamerica.io/bill/106-HR-1885/)
Report a problem